drugset / Trial / NCT02991950
Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial
RandomizedParallel-groupOpen-labelTreatment
Summary
Prospective randomized study of patients with infertility candidates to Assisted ReproductiveTechniques (ART), screened for all inclusion and exclusion criteria, submitted to ART cycle with or without low molecular weight heparin (LMWH) administration. Aims of the study are to evaluate, primarily, pregnancy rate/embryo transfer, secondarily take home babies/embryo transfer, implantation rate, and the role of thrombophilic factors
Timeline
- Start
- 2011-07
- Primary completion
- 2015-03
- Completion
- 2015-12
Outcome
Outcome not reported
Stopped (Enrollment): “Difficulty with patient enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | parnaparin | Other / unclassified | 100 iu/kg | — |
| Subject | parnaparin | Other / unclassified | 4250 iu | — |
| Subject | parnaparin | Other / unclassified | 6400 iu | — |